Deutsche Bank Begins Coverage on Cotiviti (COTV)
Deutsche Bank initiated coverage on shares of Cotiviti (NYSE:COTV) in a report issued on Friday, Marketbeat.com reports. The brokerage issued a hold rating and a $34.00 price target on the business services provider’s stock.
A number of other equities analysts have also weighed in on COTV. BidaskClub lowered shares of Cotiviti from a hold rating to a sell rating in a research note on Monday, September 18th. Mitsubishi UFJ Financial Group started coverage on shares of Cotiviti in a research note on Thursday, September 21st. They issued an overweight rating and a $42.00 target price for the company. Jefferies Group reduced their target price on shares of Cotiviti from $41.00 to $35.00 and set a hold rating for the company in a research note on Friday, November 3rd. Zacks Investment Research lowered shares of Cotiviti from a hold rating to a sell rating in a research note on Friday, November 3rd. Finally, Robert W. Baird reaffirmed a buy rating and issued a $44.00 target price on shares of Cotiviti in a research note on Friday, November 3rd. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of $40.38.
Cotiviti (NYSE COTV) opened at $32.11 on Friday. Cotiviti has a fifty-two week low of $30.84 and a fifty-two week high of $45.97. The stock has a market cap of $2,970.00 and a price-to-earnings ratio of 22.27. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.
In other Cotiviti news, CEO J Douglas Williams sold 16,655 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $31.25, for a total transaction of $520,468.75. Following the sale, the chief executive officer now directly owns 2,776,606 shares of the company’s stock, valued at approximately $86,768,937.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Jonathan Olefson sold 15,000 shares of the business’s stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $32.37, for a total transaction of $485,550.00. Following the sale, the senior vice president now directly owns 15,149 shares in the company, valued at $490,373.13. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 128,440 shares of company stock valued at $4,372,040. Company insiders own 15.80% of the company’s stock.
Large investors have recently modified their holdings of the business. Great West Life Assurance Co. Can bought a new stake in Cotiviti during the 2nd quarter worth about $107,000. BNP Paribas Arbitrage SA lifted its position in Cotiviti by 553.5% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 3,137 shares of the business services provider’s stock worth $117,000 after buying an additional 2,657 shares in the last quarter. Strategic Global Advisors LLC bought a new stake in Cotiviti during the 3rd quarter worth about $200,000. Pacer Advisors Inc. lifted its position in Cotiviti by 138.9% during the 2nd quarter. Pacer Advisors Inc. now owns 5,642 shares of the business services provider’s stock worth $210,000 after buying an additional 3,280 shares in the last quarter. Finally, Quantbot Technologies LP lifted its position in Cotiviti by 34.5% during the 2nd quarter. Quantbot Technologies LP now owns 6,420 shares of the business services provider’s stock worth $238,000 after buying an additional 1,645 shares in the last quarter. 86.18% of the stock is currently owned by hedge funds and other institutional investors.
Cotiviti Holdings, Inc is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States.
Receive News & Ratings for Cotiviti Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.